The VCBH team has been prolific in their research and publishing since becoming a COBRE and TCORS center in 2013. To date, we have more than 285 COBRE and 165 TCORS publications. For a complete list, please download our COBRE (PDF) or TCORS (PDF) publications documents. These are both regularly updated.


Highlighted Articles

The following selected articles are representative of recent VCBH research. Click on names for a complete list of their publications on PubMed.

Philip Ades, M.D.

Ades PA, Savage PD. The treatment of obesity in cardiac rehabilitation.  J Cardiopulm Rehabil Prev. 2021. In press.

Barrett K, Savage PD, Ades PA.  Effects of weight loss goal setting in cardiac rehabilitation. J Cardiopulm Rehabil Prev.  In Press.

Thomas Ahern, Ph.D., M.P.H.

Ahern TP, Sprague BL, Farina NH, Tsai E, Cuke M, Kontos D, Wood ME. Lifestyle, behavioral, and dietary risk factors in relation to mammographic breast density in women at high risk for breast cancer. Cancer Epidemiol Biomarkers Prev. 2021 Feb 22;cebp.1567.2020.

Ahern TP, Damkier P, Feddersen S, Kjærsgaard A, Lash TL, Hamilton-Dutoit S, Lythjohan CB, Ejlertsen B, Christiansen PM, Cronin-Fenton DP. Predictive pharmacogenetic biomarkers for breast cancer recurrence prevention by simvastatin. Acta Oncol. 2020 Apr 30:1-7. PMID: 32351149

Christopher J. Brady, M.D.

Brady CJ, D’Amico S, Withers N, Kim BY. Using public datasets to identify priority areas for ocular telehealth. Telemed J E Health. 2021 Feb 18. Doi: 10.1089/tmj2020.043. PMID 33600257.

Brady CJ, Liu Y. Moving from just “thinking outside the box” to doing.  JAMA Ophthalmol. 2021 Jan 28. Doi: 10.1001/jamaophthalmol.2020.6374. PMID: 33507204.

Diann E Gaalema, Ph.D.

Gaalema DE, Bolívar HA, Khadanga S, Priest JS, Higgins ST, Ades PA. Current smoking as a marker of a high-risk behavioral profile after myocardial infarction. Prev Med. 2020 Nov;140:106245. PMCID: PMC7680426.

Pericot-Valverde I, Priest JS, Wagener TL, Gaalema DE. Examination of a mouthpiece-based topography device for assessing relative reinforcing effects of e-cigarettes: A preliminary study. Exp Clin Psychopharmacol. 2020 Feb;28(1):13-18. PMID: 31305091

Sarah H. Heil, Ph.D.

Heil SH, Melbostad HS, Matusiewicz AK, Rey CN, Badger GJ, Shepard DS, Sigmon SC, MacAfee LK, Higgins ST. Efficacy and Cost-Benefit of Onsite Contraceptive Services With and Without Incentives Among Women With Opioid Use Disorder at High Risk for Unintended Pregnancy: A Randomized Clinical Trial. JAMA Psychiatry. 2021 Jul 14:e211715. doi: 10.1001/jamapsychiatry.2021.1715. Online ahead of print.PMID: 34259798

Rey CN, Badger GJ, Melbostad HS, Wachtel D, Sigmon SC, MacAfee LK, Dougherty AK, Heil SH. Perceptions of long-acting reversible contraception among women receiving medication for Opioid Use Disorder in Vermont. Contraception. 2020 Jan 31. pii: S0010-7824(20)30029-9. doi: 10.1016/j.contraception.2020.01.010. PMID: 32014521.

Stephen T. Higgins, Ph.D.

Higgins ST, DeSarno M, Bunn JY, Gaalema DE, Leventhal AM, Davis DR, Streck JM, Harfmann RF, Markesich C, Orr E, Sigmon SC, Heil SH, Tidey JW, Lee D, Hughes JR. Cumulative vulnerabilities as a potential moderator of response to reduced nicotine content cigarettes. Prev Med. 2021 Jul 6:106714. doi: 10.1016/j.ypmed.2021.106714. PMID: 34242666

Higgins ST.  2019.  Behavior change, health, and health disparities 2019: opioids, tobacco, and treatment adherence. Prev Med. 2019 Nov 9:105887. doi: 10.1016/j.ypmed.2019.105887. PMID: 31711863.

Kelly Peck, Ph.D.

Peck KR, Ochalek TA, Badger GJ, Sigmon SC. Effects of Interim Buprenorphine Treatment for opioid use disorder among emerging adults. Drug Alcohol Depend. 2020 Mar 1;208:107879. PMCID: PMC7108757.

Peck KR, Parker MA, Sigmon SC. Reasons for non-medical use of opioids among young adults in the United States: The role of educational status. Prev Med. 2019 Apr 2. doi: 10.1016/j.ypmed.2019.03.047. PMID: 30951735

Richard Rawson, Ph.D. 

Rawson RA, Rieckmann T, Cousins S, McCann M, Pearce R. Patient perceptions of treatment with medication treatment for opioid use disorder (MOUD) in the Vermont hub-and-spoke system.  Prev Med. 2019 Jul 27:105785. doi: 10.1016/j/ypmed.2019. 105785. PMID: 31362002.

Rawson R, Cousins SJ, McCann M, Pearce R, Van Donsel A.  Assessment of medication for opioid use disorder as delivered within the Vermont hub-and-spoke system.  J Subst Abuse Treat. 2019 Feb;97:84-90. PMID: 30577904.

Stacey Sigmon, Ph.D.

Streck JM, Sigmon SC, Priest J, Bergeria CL, Davis DR, Hughes JR, Villanti AC, Tidey JW, Heil SH, Gaalema DE, Stitzer ML, Higgins ST. Investigating tobacco withdrawal in response to reduced nicotine cigarettes among smokers with opioid use disorder and other vulnerabilities. Exp Clin Psychopharmacol. 2020 Feb 6. doi: 10.1037/pha0000350. PMID: 32027158.

Parker MA, Sigmon SC, Villanti AC. Higher smoking prevalence among United States adults with co-occurring affective and drug use diagnoses. Addict Behav. 2019 Aug 26;99:106112. doi: 10.1016/j.addbeh.2019.106112.

Andrea Villanti, Ph.D., M.P.H

Villanti AC, West JC, Klemperer EM, Graham AL, Mays D, Mermelstein RJ, Higgins ST. Smoking-cessation interventions for U.S. young adults: Updated systematic review. Am J Prev Med. 2020 May 14. doi: 10.1016/j.amepre.2020.01.021. PMID: 32418800.

Villanti AC, West JC, Mays D, Donny EC, Cappella JN, Strasser AA. Impact of brief nicotine messaging on nicotine-related beliefs in a U.S. sample. Am J Prev Med. 2019 Oct;57(4):e135-e142. PMID: 31542145.